CTRI/2015/02/005522招募中4 期
Multicentric follow up study to evaluate the immunogenicity of Single dose Live Attenuated Varicella Vaccine (VR 795 varicella Oka strain) in healthy Indian children up to 5 years post-vaccination.
Wockhardt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •. Healthy children of either sex who received test varicella vaccination (VR 795 varicella Oka strain) as part of the Phase III clinical trial (WOC/VAC/VAR/CT-19-PRT)
- •. Parent/guardian of subject willing to give written ICF and to comply to all study related procedures
排除标准
- •. Subjects who have not received test varicella vaccine (VR 795 varicella Oka strain) as part of the Phase III clinical trial (WOC/VAC/VAR/CT-19-PRT)
- •. Any other criteria considered by the Investigator not to be suitable for enrollment
研究者
相似试验
已完成
3 期
A clinical study to assess the continued immunological existence of antibodies at 12, 24 and 36 months after receiving the primary dose.CTRI/2020/03/023712Biological ELimited233
尚未招募
4 期
A 9th year follow up study on persitance of Hepatitis A vaccineCTRI/2017/02/007837Wockhardt Ltd150
进行中（未招募）
1 期
A multicenter, pilot study evaluating immune impact and safety of nivolumab in combination with ipilimumab (immune combination) before initial RT-CT treatment for cervix cancer. COLIBRI StudyPatients with cervical squamous cell carcinoma stage IB3 to IVaMedDRA version: 21.1Level: LLTClassification code 10008233Term: Cervical cancer stage ISystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10008234Term: Cervical cancer stage IISystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10008235Term: Cervical cancer stage IIISystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10008236Term: Cervical cancer stage IVSystem Organ Class: 100000004864EUCTR2019-002271-34-FRARCAGY-GINECO40
招募中
不适用
Multi-institutional study of immunologic response tu surgical stress in patients undergoing pulmonary lobectomyung cancerJPRN-UMIN000021182agoya City University100
进行中（未招募）
不适用
A multicenter study to describe the immunogenic epitope(s) of factor VIII in previously treated patients with congenital hemophilia A who develop de novo factor VIII inhibitors while receiving factor VIII infusion therapy - N/AHaemophilia A is an X-linked recessive clotting disorder in which the clotting factor, factor VIII (FVIII), is deficient or inactive. Patients with low levels of FVIII have an increased tendency to bleed and is characterised by recurrent haemorrhages due to trauma, surgery or spontaneous haemorrhaging when the condition is severe.EUCTR2004-000219-24-DEWyeth Pharmaceuticals27